Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Status unconfirmed

Conditions studied: Cancer

In brief

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.

Key facts

Study ID

NCT01148407

Run by

University of Vermont

People needed

30

Starts

2010-06-01

Expected to finish

2013-08-01

Last updated by the study team

2011-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a diagnosis of malignancy

You may not qualify if…

• Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy

Where it is running

• University of Vermont/Fletcher Allen Health Care — Burlington, Vermont, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.